Main Subject
#1 in Business Subscribe Email Print

You are here: Home > Business > Ethics > Selling Truth as a Differentiator

Tags

  • payments
  • regulatory
  • clients
  • investment adviser
  • developing combination

  • Links

  • Relationships - The Most Lethal Cause of Stress(2)
  • Here Are A Few Buying Tips I Learned From My Years In The Car Business
  • Adsense Secrets - Why You Should Know Them When They Are Available
  • Main Subject - Selling Truth as a Differentiator

    The last few years have been a period of heightened scrutiny and scandal for the financial services industry. Most recently, the SEC issued a r
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    eport on pension consultants regarding conflicts of interest and the objectivity of advice given to retirement plan sponsors. It’s become vital
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    to the success of insurance and financial advisors that they differentiate themselves with their exemplary ethics, that they operate by a high
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    er moral code and that they communicate that higher standard to their clients. Why? Because research proves that ethics builds trust, and trust
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    sells — in the long-term and - in the short-term, as well.

    Taken from the SEC report and the information provided by the Dept of Labor, below
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    are Affirmations of Ethical Behavior for Financial and Insurance Industry Representatives. The Ten Affirmations of Ethical Behavior

    1. If reg
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    istered with the SEC or a state securities regulator as an investment adviser I will provide my clients with all the disclosures required under
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    those laws (including Part II of Form ADY).

    2. I will describe any relationship I have with money managers that I recommend, consider for reco
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    mmendation, or otherwise mention to the plan.

    3. I will describe any payments I receive from money managers I recommend, consider for recommen
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    dation, or otherwise mention to the plan for consideration.

    4. I have prepared policies and procedures to address conflicts of interest or
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    o prevent conflicting payments or relationships from being a factor when providing advice to my clients.

    5. I will monitor and reconcile the a
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    mount of commissions paid when using brokerage commissions to pay consulting fees and alert plan sponsors when consulting fees have been paid i
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    n full.

    6. I have established procedural steps to ensure that the plan receives the best execution for its securities trades when the consulti
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ng fees are paid with the plan’s brokerage commissions.

    7. I will describe any arrangements with broker-dealers under which I will benefit if
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    oney managers place trades for their clients with such broker-dealers.

    8. If hired, I will acknowledge in writing whether or not I have a fidu
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ciary obligation as an investment adviser to the plan while providing consulting services.

    9. I will acknowledge whether or not I consider mys
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    elf a fiduciary under ERISA with respect to the recommendations I provide the plan?

    10. I will describe the percentage of my plan clients that
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    utilize money managers, investment funds, brokerage services or other service providers from whom I receive fees?

    Post these affirmations on y
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    our website and include them in your marketing materials. If you complete the affirmations for prospective clients, you will have distanced you
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    rself from the scandal ridden and differentiated yourself in an industry where the value added to products and services is quickly commoditized


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.mainsubjects.org.ua/article/19033/mainsubjects-Selling-Truth-as-a-Differentiator.html">Selling Truth as a Differentiator</a>

    BB link (for phorums):
    [url=http://www.mainsubjects.org.ua/article/19033/mainsubjects-Selling-Truth-as-a-Differentiator.html]Selling Truth as a Differentiator[/url]

    Related Articles:

    Focus On White-Collar Crime: Accounting Fraud and Computer Crimes Creates Need; Qualified Investing

    The Global Work Marketplace - The Revolution Of How Work Gets Done

    Track Each Complaint Until Your Customer Comes Back

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com